½ÃÀ庸°í¼­
»óǰÄÚµå
1813348

¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç°º°, ¸ð´ÏÅ͸µ ÆÄ¶ó¹ÌÅͺ°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Anesthesia Monitoring Devices Market Forecasts to 2032 - Global Analysis By Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors and Other Products), Monitoring Parameter, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀº 2025³â 20¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í ¿¹Ãø ±â°£ µ¿¾È CAGR 11.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç 2032³â¿¡´Â 43¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡´Â ¼ö¼ú ÀýÂ÷ Áß ¸¶Ãë »óÅ¿¡ Àִ ȯÀÚÀÇ »ý¸®Àû ±â´ÉÀ» Áö¼ÓÀûÀ¸·Î Æò°¡Çϱâ À§ÇØ »ç¿ëµÇ´Â Àü¹® ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ±â±âµéÀº »ê¼ÒÈ­, ȯ±â, ¼øÈ¯, ü¿Â, ½Å°æ±Ù Ȱµ¿ µîÀÇ ¸Å°³º¯¼ö¸¦ ÃßÀûÇÏ¿© ȯÀÚ ¾ÈÀü°ú ÃÖÀûÀÇ ¸¶Ãë ±íÀ̸¦ º¸ÀåÇÕ´Ï´Ù. ÀϹÝÀûÀÎ °ø±¸·Î´Â ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â, Ä«ÇÁ³ë±×·¡ÇÁ, ½ÉÀüµµ, Ç÷¾Ð ¸ð´ÏÅ͸µ, ³úÆÄ ±â¹Ý ¸¶Ãë ±íÀÌ ¸ð´ÏÅ͸µ µîÀÌ ÀÖ½À´Ï´Ù. ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ¸¶Ãë°ú Àǻ簡 »ý¸®ÇÐÀû º¯È­¸¦ ½Å¼ÓÇÏ°Ô °¨ÁöÇÏ°í ´ëÀÀÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ÇÕº´Áõ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. °í±Þ ½Ã½ºÅÛÀº ÀÇ»ç °áÁ¤°ú °á°ú Çâ»óÀ» À§ÇØ AI ¹× ¿¹Ãø ºÐ¼®À» Á¡Á¡ ´õ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¾ÈÁ¤¼º À¯Áö¿Í ¼ö¼ú Áß ÀÇ½Ä È¸º¹ ¹æÁö¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¼ö¼ú °Ç¼ö Áõ°¡

°í·ÉÈ­ Àα¸, ¿Ü»ó »ç·Ê, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡·Î ÀÎÇÑ Àü ¼¼°èÀû ¼ö¼ú °Ç¼ö Áõ°¡´Â ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ äÅÃÀÇ ÇÙ½É ÃËÁø ¿äÀÎÀÔ´Ï´Ù. ¼ö¼úÀÌ ´õ º¹ÀâÇØÁö°í ºó¹øÇØÁü¿¡ µû¶ó Á¤¹ÐÇÑ ¼ö¼ú Áß ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̵é ÀåÄ¡´Â ȯÀÚ ¾ÈÀüÀ» º¸ÀåÇÏ°í ¸¶Ãë ±íÀ̸¦ ÃÖÀûÈ­Çϸç ÇÕº´ÁõÀ» °¨ÃàÇÕ´Ï´Ù. ¿Ü·¡ ¹× ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ±ÞÁõÀº ÈÞ´ë¿ë ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺À» ´õ¿í ÁõÆø½ÃÄÑ ÀÌ µ¿ÇâÀ» ÁÖ¿ä ¼ºÀå ÃËÁø ¿äÀÎÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ÀåÄ¡ÀÇ ³ôÀº ºñ¿ë

±â¼úÀû ¹ßÀü¿¡µµ ºÒ±¸Çϰí, ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ³ôÀº ºñ¿ëÀº ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­ ¿©ÀüÈ÷ »ó´çÇÑ À庮À¸·Î ³²¾Æ ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI), ³úÆÄ(EEG), ´ÙÁß ¸Å°³º¯¼ö ºÐ¼®À» ÅëÇÕÇÑ °í±Þ ½Ã½ºÅÛÀº »ó´çÇÑ ÀÚº» ÅõÀÚ¿Í Áö¼ÓÀûÀÎ À¯Áöº¸¼ö¸¦ ¿ä±¸ÇÕ´Ï´Ù. ¼Ò±Ô¸ð º´¿ø ¹× Ŭ¸®´ÐÀº °æÁ¦¼º ¹®Á¦·Î ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ¾î ±¤¹üÀ§ÇÑ µµÀÔÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °ø°ø ÀÇ·á ½Ã½ºÅÛÀÇ º¸Çè±Þ¿© ¹®Á¦¿Í ¿¹»ê Á¦¾à ¿äÀÎÀº ½ÃÀå ħÅõ¸¦ ´õ¿í ÀúÇØÇϸç, ƯÈ÷ ºñ¿ë È¿À²¼ºÀÌ ±¸¸Å °áÁ¤¿¡ Áß¿äÇÑ ½ÅÈï °æÁ¦±¹¿¡¼­ ´õ¿í µÎµå·¯Áý´Ï´Ù.

±â¼ú ¹ßÀü

¼¾¼­ ±â¼ú, ÀΰøÁö´É ÅëÇÕ, ¿¹Ãø ºÐ¼® ºÐ¾ßÀÇ ±Þ¼ÓÇÑ Çõ½ÅÀº ¸¶Ãë ¸ð´ÏÅ͸µ¿¡ º¯ÇõÀû ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ½º¸¶Æ® ½Ã½ºÅÛÀº ÀÌÁ¦ ½Ç½Ã°£ °æº¸, ÀûÀÀÇü ¸¶ÃëÁ¦ Åõ¿©, Çâ»óµÈ ½Å°æ±Ù ÃßÀûÀ» Á¦°øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ¿¬°á¼º°ú ÀüÀڰǰ­±â·Ï(EHR)°úÀÇ »óÈ£¿î¿ë¼ºÀº ¾÷¹« È¿À²¼º°ú ÀÓ»ó ÀÇ»ç°áÁ¤À» °³¼±ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚ ¾ÈÀüÀ» ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó Á¤¹ÐÀÇÇÐ Á¢±Ù¹ýÀ» µÞ¹ÞħÇÕ´Ï´Ù. ÀÇ·á°¡ µ¥ÀÌÅÍ ±â¹Ý Ä¡·á·Î ÀüȯµÊ¿¡ µû¶ó ÇâÈÄ ¸ð´ÏÅ͸µ ÀåÄ¡´Â ¼ö¼ú ÀüÈÄ °ü¸® ¹æ½ÄÀ» ÀçÁ¤ÀÇÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç

Áö¿ªº° ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå È®Àå¿¡ µµÀü °úÁ¦¸¦ Á¦±âÇÕ´Ï´Ù. FDA, CE ¹× ±âŸ ±¹Á¦ Ç¥ÁØ Áؼö´Â ¾ö°ÝÇÑ ÀÓ»ó °ËÁõ, ¹®¼­È­ ¹× ½ÃÆÇ ÈÄ °¨½Ã¸¦ ¿ä±¸ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀýÂ÷´Â Á¦Ç° Ãâ½Ã¸¦ Áö¿¬½ÃŰ°í °³¹ß ºñ¿ëÀ» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁøÈ­ÇÏ´Â µ¥ÀÌÅÍ °³ÀÎÁ¤º¸ º¸È£¹ý°ú ¿¬°áµÈ ±â±â¿¡ ´ëÇÑ »çÀ̹ö º¸¾È Àǹ«´Â º¹À⼺À» °¡Áß½Ãŵ´Ï´Ù. Á¦Á¶¾÷ü´Â Çõ½ÅÀ» º¸ÀåÇϸ鼭 ÀÌ·¯ÇÑ Àå¾Ö¹°À» ±Øº¹ÇØ¾ß Çϸç, ÀÌ´Â ¼Ò±Ô¸ð ¾÷ü¸¦ À§Ãà½Ã۰í Ãֽűâ¼ú ¼Ö·ç¼ÇÀÇ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÊÃâ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ ¼¼°èÀûÀ¸·Î ¼±ÅÃÀû ¼ö¼úÀ» ÁߴܽÃÄÑ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ¼ö¿ä¸¦ ÀϽÃÀûÀ¸·Î À§Ãà½ÃÄ×½À´Ï´Ù. ±×·¯³ª ÀÌ À§±â´Â ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ °í±Þ ¸ð´ÏÅ͸µÀÇ Á߿伺À» ºÎ°¢½ÃÄÑ ÁßȯÀÚ½Ç(ICU) ¹× ÀÀ±Þ ½Ã¼ú¿¡¼­ÀÇ µµÀÔÀ» °¡¼ÓÈ­Çß½À´Ï´Ù. ÆÒµ¥¹Í ÀÌÈÄ È¸º¹¼¼·Î ¼ö¼ú °Ç¼ö°¡ ´Ù½Ã Áõ°¡ÇßÀ¸¸ç, È£Èí ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í´Â »ê¼ÒÈ­ Á᫐ ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀ» ³ô¿´½À´Ï´Ù. ÆÒµ¥¹ÍÀº ¶ÇÇÑ µðÁöÅÐ ÀüȯÀ» ÃËÁøÇÏ¿© º´¿øµéÀÌ È¸º¹Åº·Â¼º°ú ´ëºñ¸¦ À§ÇØ ´õ ½º¸¶Æ®ÇÏ°í ¿ø°Ý ±â´ÉÀÌ °¡´ÉÇÑ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ÅõÀÚÇϵµ·Ï À¯µµÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Á¤Çü¿Ü°ú ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»ó

Á¤Çü¿Ü°ú ¼ö¼ú ºÎ¹®Àº ³ôÀº ½Ã¼ú·®°ú º¹À⼺À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» ±â·ÏµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °üÀý ġȯ¼ú, ôÃß ¼ö¼ú, ¿Ü»ó ÁßÀç¼úÀº Àå½Ã°£ ¸¶Ãë¿Í ¼¼½ÉÇÑ »ý¸®ÇÐÀû ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. °í·ÉÈ­ Àα¸¿Í ±Ù°ñ°Ý°è Áúȯ ¹ß»ý·ü Áõ°¡°¡ ¼ö¿ä¸¦ ´õ¿í ºÎÃß±â°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº »ó´çÇÑ ÃâÇ÷°ú ½Å°æ±Ù °ü¸®°¡ ¼ö¹ÝµÇ´Â °æ¿ì°¡ ¸¹¾Æ, ¼ö¼ú Áß ¾ÈÁ¤¼º°ú ¼ö¼ú ÈÄ È¸º¹À» À§ÇØ °í±Þ ¸ð´ÏÅ͸µÀÌ ÇʼöÀûÀ̸ç, ÀÌ´Â Áö¼ÓÀûÀÎ ±â±â Ȱ¿ëÀ» ÃËÁøÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀº »ê¼ÒÈ­ ¸ð´ÏÅ͸µ ºÎ¹®

¿¹Ãø ±â°£ µ¿¾È »ê¼ÒÈ­ ¸ð´ÏÅ͸µ ºÎ¹®Àº Àú»ê¼ÒÁõ °¨Áö¿Í ¸¶Ãë Áß È£Èí ¾ÈÁ¤¼º È®º¸¿¡ ÀÖ¾î ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇÔ¿¡ µû¶ó °¡Àå ³ôÀº ¼ºÀå·üÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â¿Í °í±Þ »ê¼Ò ¼¾¼­°¡ ´ÙÁß ¸Å°³º¯¼ö ½Ã½ºÅÛ¿¡ Á¡Á¡ ´õ ÅëÇյǸ鼭 ½Ç½Ã°£ Çǵå¹é°ú Á¶±â °æº¸ ±â´ÉÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °íÀ§Çè ¼ö¼ú ¹× ¼Ò¾Æ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ È¯ÀÚ ¾ÈÀü¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡ÇÔ¿¡ µû¶ó µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¹× ¹«¼± »ê¼ÒÈ­ ¸ð´ÏÅÍÀÇ Çõ½ÅÀº ¶ÇÇÑ »ç¿ë ¹üÀ§¸¦ ¼ö¼ú½ÇÀ» ¿Ü¿¡ ¿Ü·¡ ¹× ÀçÅà ġ·á ȯ°æÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº Áõ°¡ÇÏ´Â ¼ö¼ú °Ç¼ö, È®´ëµÇ´Â ÀÇ·á ÀÎÇÁ¶ó, ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀº º´¿øÀÇ ±Þ¼ÓÇÑ Çö´ëÈ­¿Í °í±Þ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¼ö¼ú ÀüÈÄ °ü¸® °³¼±À» À§ÇÑ Á¤ºÎ Á¤Ã¥°ú ¹Î°£ ÀÇ·á Á¦°øÀÚÀÇ È®»êÀÌ ½ÃÀåÀ» ´õ¿í µÞ¹ÞħÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ¹æ´ëÇÑ È¯ÀÚ Ç®°ú À¯¸®ÇÑ º¸Çè Àû¿ë Á¤Ã¥Àº ±â±â Á¢±Ù¼º°ú äÅ÷üÀ» Çâ»ó½Ãŵ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì Áö¿ªÀº °­·ÂÇÑ ÀÇ·á ÁöÃâ, ±â¼ú Çõ½Å, ¾ö°ÝÇÑ È¯ÀÚ ¾ÈÀü ÇÁ·ÎÅäÄÝ·Î ÀÎÇØ °¡Àå ³ôÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â ÀΰøÁö´É ±â¹Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ÅëÇÕ ¹× Á¤¹Ð ¸¶Ãë °üÇà µµÀÔ¿¡¼­ ¼±µµÀû À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °­·ÂÇÑ ±ÔÁ¦ °¨µ¶Àº ³ôÀº ±â±â ǰÁúÀ» º¸ÀåÇϸç, º¸»ó ü°è´Â ÀÔ¿ø ¹× ¿Ü·¡ ȯÀÚ È¯°æ ¸ðµÎ¿¡¼­ °í±Þ ¸ð´ÏÅ͸µÀ» µÞ¹ÞħÇÕ´Ï´Ù. °¡Ä¡ ±â¹Ý ÀÇ·á ¹× µðÁöÅÐ Çコ ÅëÇÕ¿¡ ´ëÇÑ ÇØ´ç Áö¿ªÀÇ ÁÖ·ÂÇÔÀº Áö¼ÓÀûÀÎ ½ÃÀå È®Àå°ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç ÀÚ·á
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç°ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå : Á¦Ç°º°

  • ±âº» ¸¶Ãë ¸ð´ÏÅ͸µ
  • °í±Þ ¸¶Ãë ¸ð´ÏÅ͸µ
    • ÅëÇÕ ¸¶Ãë ¿öÅ©½ºÅ×À̼Ç
    • ¸¶Ãë Á¤µµ ¸ð´ÏÅ͸µ
    • µ¶¸³Çü Ä«ÇÁ³ë±×·¡ÇÇ ¸ð´ÏÅ͸µ
    • MRI ´ëÀÀ ¸¶Ãë ¸ð´ÏÅ͸µ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå : ¸ð´ÏÅ͸µ ÆÄ¶ó¹ÌÅͺ°

  • »ê¼ÒÈ­ ¸ð´ÏÅ͸µ
  • ȯ±â ¸ð´ÏÅ͸µ
  • ¼øÈ¯ ¸ð´ÏÅ͸µ
  • ü¿Â ¸ð´ÏÅ͸µ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå : ¿ëµµº°

  • ½ÉÀå¿Ü°ú
  • ½Å°æ¿Ü°ú
  • Á¤Çü¿Ü°ú
  • ºñ´¢±â°ú
  • È£Èí±â ¼ö¼ú
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¸¶Ãë ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Philips
  • GE Healthcare
  • Drager
  • Masimo
  • Nihon Kohden
  • Mindray
  • Spacelabs Healthcare
  • Smiths Medical
  • B. Braun Melsungen
  • Getinge
  • Zoll Medical
  • Medtronic
  • Nonin Medical
  • Edwards Lifesciences
  • Schiller AG
HBR 25.10.01

According to Stratistics MRC, the Global Anesthesia Monitoring Devices Market is accounted for $2.0 billion in 2025 and is expected to reach $4.3 billion by 2032 growing at a CAGR of 11.2% during the forecast period. Anesthesia monitoring devices are specialized instruments used during surgical procedures to continuously assess a patient's vital physiological functions while under anesthesia. These devices track parameters such as oxygenation, ventilation, circulation, temperature, and neuromuscular activity to ensure patient safety and optimal anesthetic depth. Common tools include pulse oximeters, capnographs, electrocardiograms, blood pressure monitors, and EEG-based depth-of-anesthesia monitors. By providing real-time data, they enable anesthesiologists to detect and respond to physiological changes promptly, minimizing risks of complications. Advanced systems increasingly integrate AI and predictive analytics to enhance decision-making and improve outcomes. These devices are essential for maintaining stability and preventing intraoperative awareness.

Market Dynamics:

Driver:

Rising Surgical Procedures

The global rise in surgical procedures-driven by aging populations, trauma cases, and chronic disease prevalence-is a key catalyst for anesthesia monitoring device adoption. As surgeries become more complex and frequent, the demand for precise intraoperative monitoring intensifies. These devices ensure patient safety, optimize anesthetic depth, and reduce complications. The surge in outpatient and minimally invasive surgeries further amplifies the need for portable, real-time monitoring solutions, positioning this trend as a major growth driver.

Restraint:

High Costs of Devices

Despite technological advancements, the high cost of anesthesia monitoring devices remains a significant barrier, especially in low-resource settings. Advanced systems integrating AI, EEG, and multi-parameter analytics demand substantial capital investment and ongoing maintenance. Smaller hospitals and clinics may struggle with affordability, limiting widespread adoption. Additionally, reimbursement challenges and budget constraints in public healthcare systems further dampen market penetration, particularly in emerging economies where cost-efficiency is critical for procurement decisions.

Opportunity:

Technological Advancements

Rapid innovation in sensor technology, AI integration, and predictive analytics presents a transformative opportunity for anesthesia monitoring. Smart systems now offer real-time alerts, adaptive anesthetic dosing, and enhanced neuromuscular tracking. Cloud connectivity and interoperability with electronic health records improve workflow efficiency and clinical decision-making. These advancements not only elevate patient safety but also support precision medicine approaches. As healthcare shifts toward data-driven care, next-gen monitoring devices are poised to redefine perioperative management.

Threat:

Stringent Regulatory Requirements

Stringent regulatory frameworks across regions pose a challenge to market expansion. Compliance with FDA, CE, and other international standards requires rigorous clinical validation, documentation, and post-market surveillance. These processes can delay product launches and increase development costs. Moreover, evolving data privacy laws and cybersecurity mandates for connected devices add complexity. Manufacturers must navigate these hurdles while ensuring innovation, which may deter smaller players and slow down time-to-market for cutting-edge solutions.

Covid-19 Impact

The COVID-19 pandemic disrupted elective surgeries globally, temporarily dampening demand for anesthesia monitoring devices. However, the crisis underscored the importance of advanced monitoring in critical care settings, accelerating adoption in ICUs and emergency procedures. Post-pandemic recovery has reignited surgical volumes, while heightened awareness of respiratory monitoring has boosted interest in oxygenation-focused technologies. The pandemic also catalyzed digital transformation, prompting hospitals to invest in smarter, remote-capable monitoring systems for resilience and preparedness.

The orthopedic surgeries segment is expected to be the largest during the forecast period

The orthopedic surgeries segment is expected to account for the largest market share during the forecast period, due to their high procedural volume and complexity. Joint replacements, spinal surgeries, and trauma interventions require prolonged anesthesia and meticulous physiological monitoring. The aging population and rising incidence of musculoskeletal disorders further fuel demand. These procedures often involve significant blood loss and neuromuscular management, making advanced monitoring essential for intraoperative stability and postoperative recovery, thereby driving sustained device utilization.

The oxygenation monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the oxygenation monitoring segment is predicted to witness the highest growth rate, due to its critical role in detecting hypoxia and ensuring respiratory stability during anesthesia. Pulse oximeters and advanced oxygen sensors are increasingly integrated into multi-parameter systems, offering real-time feedback and early warning capabilities. The growing emphasis on patient safety, especially in high-risk surgeries and pediatric cases, is accelerating adoption. Innovations in wearable and wireless oxygenation monitors are also expanding use beyond operating rooms into ambulatory and home care settings.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising surgical volumes, expanding healthcare infrastructure, and increasing investments in medical technology. Countries like China, India, and Japan are witnessing rapid hospital modernization and growing demand for advanced monitoring solutions. Government initiatives to improve perioperative care and the proliferation of private healthcare providers further support market growth. Additionally, the region's large patient pool and favorable reimbursement policies enhance device accessibility and adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to robust healthcare spending, technological innovation, and stringent patient safety protocols. The U.S. and Canada lead in integrating AI-powered monitoring systems and adopting precision anesthesia practices. Strong regulatory oversight ensures high device quality, while reimbursement frameworks support advanced monitoring in both inpatient and outpatient settings. The region's focus on value-based care and digital health integration continues to propel rapid market expansion and innovation.

Key players in the market

Some of the key players profiled in the Anesthesia Monitoring Devices Market include Philips, GE Healthcare, Drager, Masimo, Nihon Kohden, Mindray, Spacelabs Healthcare, Smiths Medical, B. Braun Melsungen, Getinge, Zoll Medical, Medtronic, Nonin Medical, Edwards Lifesciences and Schiller AG.

Key Developments:

In June 2025, Philips and Medtronic have expanded their longstanding partnership, through a new multi-year agreement aimed at enhancing access to advanced patient monitoring technologies. This collaboration integrates Medtronic's leading brands-Nellcor(TM) pulse oximetry, Microstream(TM) capnography, and BIS(TM) brain monitoring-into Philips' patient monitoring systems.

In November 2024, GE HealthCare and RadNet's DeepHealth have announced a strategic collaboration to advance AI integration in medical imaging. This partnership aims to develop SmartTechnology(TM) solutions that enhance imaging interpretation, streamline workflows, and improve clinical outcomes.

Products Covered:

  • Basic Anesthesia Monitors
  • Advanced Anesthesia Monitors
  • Other Products

Monitoring Parameters Covered:

  • Oxygenation Monitoring
  • Ventilation Monitoring
  • Circulation Monitoring
  • Temperature Monitoring
  • Other Monitoring Parameters

Applications Covered:

  • Cardiac Surgeries
  • Neurological Surgeries
  • Orthopedic Surgeries
  • Urological Surgeries
  • Respiratory Surgeries
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Anesthesia Monitoring Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Basic Anesthesia Monitors
  • 5.2 Advanced Anesthesia Monitors
    • 5.3.1 Integrated Anesthesia Workstations
    • 5.3.2 Depth of Anesthesia Monitors
    • 5.3.3 Standalone Capnography Monitors
    • 5.3.4 MRI-Compatible Anesthesia Monitors
  • 5.4 Other Products

6 Global Anesthesia Monitoring Devices Market, By Monitoring Parameter

  • 6.1 Introduction
  • 6.2 Oxygenation Monitoring
  • 6.3 Ventilation Monitoring
  • 6.4 Circulation Monitoring
  • 6.5 Temperature Monitoring
  • 6.6 Other Monitoring Parameters

7 Global Anesthesia Monitoring Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiac Surgeries
  • 7.3 Neurological Surgeries
  • 7.4 Orthopedic Surgeries
  • 7.5 Urological Surgeries
  • 7.6 Respiratory Surgeries
  • 7.7 Other Applications

8 Global Anesthesia Monitoring Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Specialty Clinics
  • 8.5 Other End Users

9 Global Anesthesia Monitoring Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Philips
  • 11.2 GE Healthcare
  • 11.3 Drager
  • 11.4 Masimo
  • 11.5 Nihon Kohden
  • 11.6 Mindray
  • 11.7 Spacelabs Healthcare
  • 11.8 Smiths Medical
  • 11.9 B. Braun Melsungen
  • 11.10 Getinge
  • 11.11 Zoll Medical
  • 11.12 Medtronic
  • 11.13 Nonin Medical
  • 11.14 Edwards Lifesciences
  • 11.15 Schiller AG
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦